glp-1 prescriptions growth slowing 2024 Are Up, Health Services Utilization Down, and GLP-1s Are a Major Driver: IQVIA's Update Monitoring GLP-1 RA prescription trends

Features of a successful therapeutic fast of 382 days duration

IGF-1 LR3: Potential for hypoglycemia due to insulin receptor cross-reactivity

Electron microscopy performed in aged non-human primates and rodents have further clarified this deterioration by revealing the structural alterations present in the myelin sheath, such as redundant myelination and reduced myelin thickness (Figure 1

In the SUSTAIN 6 trial, over 3,297 patients with type 2 diabetes with established chronic kidney disease and/or cardiovascular disease underwent randomization to semaglutide or placebo and were followed for 2 years resulting in a 26% risk reduction in the combined endpoint of rate of cardiovascular disease, nonfatal myocardial infarction, or nonfatal stroke [47]

M., Van Eyk, J